|
1
|
Giudice LC and Kao LC: Endometriosis.
Lancet. 364:1789–1799. 2004.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Rogers PA, D'Hooghe TM, Fazleabas A,
Gargett CE, Giudice LC, Montgomery GW, Rombauts L, Salamonsen LA
and Zondervan KT: Priorities for endometriosis research:
Recommendations from an international consensus workshop. Reprod
Sci. 16:335–346. 2009.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pearce CL, Templeman C, Rossing MA, Lee A,
Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund
KG, et al: Association between endometriosis and risk of
histological subtypes of ovarian cancer: A pooled analysis of
case-control studies. Lancet Oncol. 13:385–394. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fukunaga M, Nomura K, Ishikawa E and
Ushigome S: Ovarian atypical endometriosis: Its close association
with malignant epithelial tumours. Histopathology. 30:249–255.
1997.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Machida H, Matsuo K, Yamagami W, Ebina Y,
Kobayashi Y, Tabata T, Kanauchi M, Nagase S, Enomoto T and Mikami
M: Trends and characteristics of epithelial ovarian cancer in Japan
between 2002 and 2015: A JSGO-JSOG joint study. Gynecol Oncol.
153:589–596. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hooper G: The diagnosis and treatment of
endometriosis. Can Med Assoc J. 42:243–246. 1940.PubMed/NCBI
|
|
7
|
Clement PB: The pathology of
endometriosis: A survey of the many faces of a common disease
emphasizing diagnostic pitfalls and unusual and newly appreciated
aspects. Adv Anat Pathol. 14:241–260. 2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yamaguchi K, Mandai M, Toyokuni S,
Hamanishi J, Higuchi T, Takakura K and Fujii S: Contents of
endometriotic cysts, especially the high concentration of free
iron, are a possible cause of carcinogenesis in the cysts through
the iron-induced persistent oxidative stress. Clin Cancer Res.
14:32–40. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fujimoto Y, Imanaka S, Yamada Y, Ogawa K,
Ito F, Kawahara N, Yoshimoto C and Kobayashi H: Comparison of redox
parameters in ovarian endometrioma and its malignant
transformation. Oncol Lett. 16:5257–5264. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Greenshields AL, Shepherd TG and Hoskin
DW: Contribution of reactive oxygen species to ovarian cancer cell
growth arrest and killing by the anti-malarial drug artesunate. Mol
Carcinog. 56:75–93. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Gunshin H, Mackenzie B, Berger UV, Gunshin
Y, Romero MF, Boron WF, Nussberger S, Gollan JL and Hediger MA:
Cloning and characterization of a mammalian proton-coupled
metal-ion transporter. Nature. 388:482–488. 1997.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Tabuchi M, Yoshimori T, Yamaguchi K,
Yoshida T and Kishi F: Human NRAMP2/DMT1, which mediates iron
transport across endosomal membranes, is localized to late
endosomes and lysosomes in HEp-2 cells. J Biol Chem.
275:22220–22228. 2000.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ross SL, Tran L, Winters A, Lee KJ, Plewa
C, Foltz I, King C, Miranda LP, Allen J, Beckman H, et al:
Molecular mechanism of hepcidin-mediated ferroportin
internalization requires ferroportin lysines, not tyrosines or
JAK-STAT. Cell Metab. 15:905–917. 2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gammella E, Buratti P, Cairo G and
Recalcati S: The transferrin receptor: The cellular iron gate.
Metallomics. 9:1367–1375. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mantovani A, Sozzani S, Locati M, Allavena
P and Sica A: Macrophage polarization: Tumor-associated macrophages
as a paradigm for polarized M2 mononuclear phagocytes. Trends
Immunol. 23:549–555. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Yamada Y, Uchiyama T, Ito F, Kawahara N,
Ogawa K, Obayashi C and Kobayashi H: Clinical significance of M2
macrophages expressing heme oxygenase-1 in malignant transformation
of ovarian endometrioma. Pathol Res Pract. 215:639–643.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Canet B, Pons C, Espinosa I and Prat J:
CDC42-positive macrophages may prevent malignant transformation of
ovarian endometriosis. Hum Pathol. 43:720–725. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Toki T, Shimizu M, Takagi Y, Ashida T and
Konishi I: CD10 is a marker for normal and neoplastic endometrial
stromal cells. Int J Gynecol Pathol. 21:41–47. 2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chandler RL, Damrauer JS, Raab JR,
Schisler JC, Wilkerson MD, Didion JP, Starmer J, Serber D, Yee D,
Xiong J, et al: Coexistent ARID1A-PIK3CA mutations promote ovarian
clear-cell tumorigenesis through pro-tumorigenic inflammatory
cytokine signalling. Nat Commun. 6(6118)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yamamoto S, Tsuda H, Takano M, Tamai S and
Matsubara O: Loss of ARID1A protein expression occurs as an early
event in ovarian clear-cell carcinoma development and frequently
coexists with PIK3CA mutations. Mod Pathol. 25:615–624.
2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Samartzis EP, Noske A, Dedes KJ, Fink D
and Imesch P: ARID1A mutations and PI3K/AKT pathway alterations in
endometriosis and endometriosis-associated ovarian carcinomas. Int
J Mol Sci. 14:18824–18849. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Huang HN, Lin MC, Huang WC, Chiang YC and
Kuo KT: Loss of ARID1A expression and its relationship with
PI3K-Akt pathway alterations and ZNF217 amplification in ovarian
clear cell carcinoma. Mod Pathol. 27:983–990. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ray PD, Huang BW and Tsuji Y: Reactive
oxygen species (ROS) homeostasis and redox regulation in cellular
signaling. Cell Signal. 24:981–990. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Donovan A, Lima CA, Pinkus JL, Pinkus GS,
Zon LI, Robine S and Andrews NC: The iron exporter
ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab.
1:191–200. 2005.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Schümann K, Moret R, Künzle H and Kühn LC:
Iron regulatory protein as an endogenous sensor of iron in rat
intestinal mucosa. Possible implications for the regulation of iron
absorption. Eur J Biochem. 260:362–372. 1999.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Miyazawa M, Bogdan AR, Hashimoto K and
Tsuji Y: Regulation of transferrin receptor-1 mRNA by the interplay
between IRE-binding proteins and miR-7/miR-141 in the 3'-IRE
stem-loops. RNA. 24:468–479. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Miller LD, Coffman LG, Chou JW, Black MA,
Bergh J, D'Agostino R Jr, Torti SV and Torti FM: An iron regulatory
gene signature predicts outcome in breast cancer. Cancer Res.
71:6728–6737. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xue X, Ramakrishnan SK, Weisz K, Triner D,
Xie L, Attili D, Pant A, Győrffy B, Zhan M, Carter-Su C, et al:
Iron uptake via DMT1 integrates cell cycle with JAK-STAT3 signaling
to promote colorectal tumorigenesis. Cell Metab. 24:447–461.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Basuli D, Tesfay L, Deng Z, Paul B,
Yamamoto Y, Ning G, Xian W, McKeon F, Lynch M, Crum CP, et al: Iron
addiction: A novel therapeutic target in ovarian cancer. Oncogene.
36:4089–4099. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Takaishi K, Komohara Y, Tashiro H, Ohtake
H, Nakagawa T, Katabuchi H and Takeya M: Involvement of
M2-polarized macrophages in the ascites from advanced epithelial
ovarian carcinoma in tumor progression via Stat3 activation. Cancer
Sci. 101:2128–2136. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tran-Harding K, Nair RT, Dawkins A, Ayoob
A, Owen J, Deraney S, Lee JT, Stevens S and Ganesh H: Endometriosis
revisited: An imaging review of the usual and unusual
manifestations with pathological correlation. Clin Imaging.
52:163–171. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wiegand KC, Shah SP, Al-Agha OM, Zhao Y,
Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, et
al: ARID1A mutations in endometriosis-associated ovarian
carcinomas. N Engl J Med. 363:1532–1543. 2010.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yachida N, Yoshihara K, Suda K, Nakaoka H,
Ueda H, Sugino K, Yamaguchi M, Mori Y, Yamawaki K, Tamura R, et al:
ARID1A protein expression is retained in ovarian endometriosis with
ARID1A loss-of-function mutations: Implication for the two-hit
hypothesis. Sci Rep. 10(14260)2020.PubMed/NCBI View Article : Google Scholar
|
